Global Tuberculosis (TB) Diagnostics Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 1370

Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss.
The increasing number of government and non-government initiatives to eradicate tuberculosis (TB) is expected to be one of the primary drivers for the global tuberculosis (TB) diagnostics market growth till 2023. A global TB control program was introduced by the US Agency for International Development (USAID) in the year 1998. To support the eradication of TB, the US prioritized and provided increased funding for bilateral and multilateral programs in the subsequent decades. Similarly, the division of tuberculosis elimination (DTBE), adopted strategic plans to control TB in the US. These programs reduce the incidence and mortality by 50%.
The increasing prevalence of TB and rising population in APAC is driving the growth prospects for the global tuberculosis (TB) diagnostics market in the region. The governments in the region are motivated to take measures to improve the healthcare infrastructure. They are also extensively focusing on the preventive care due to the rising population, especially in China and India. Furthermore, the enhancement of healthcare infrastructure in countries such as Singapore, Japan, Australia, and South Korea will boost the adoption of tuberculosis diagnostics in the APAC region.
In 2018, the global Tuberculosis (TB) Diagnostics market size was 2040 million US$ and it is expected to reach 2770 million US$ by the end of 2025, with a CAGR of 3.9% during 2019-2025.

This report focuses on the global Tuberculosis (TB) Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Tuberculosis (TB) Diagnostics development in United States, Europe and China.

The key players covered in this study
Abbott
BD
bioMérieux
F. Hoffmann-La Roche
Thermo Fisher Scientific
...

Market segment by Type, the product can be split into
Smear Microscopy
Molecular Testing
Mantoux Tuberculin Test
Culture
Drug Susceptibility Testing
LF-LAM for PLHIV

Market segment by Application, split into
Diagnostic Laboratories
Hospitals

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Tuberculosis (TB) Diagnostics status, future forecast, growth opportunity, key market and key players.
To present the Tuberculosis (TB) Diagnostics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Tuberculosis (TB) Diagnostics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Tuberculosis (TB) Diagnostics Market Size Growth Rate by Type (2014-2025)
1.4.2 Smear Microscopy
1.4.3 Molecular Testing
1.4.4 Mantoux Tuberculin Test
1.4.5 Culture
1.4.6 Drug Susceptibility Testing
1.4.7 LF-LAM for PLHIV
1.5 Market by Application
1.5.1 Global Tuberculosis (TB) Diagnostics Market Share by Application (2014-2025)
1.5.2 Diagnostic Laboratories
1.5.3 Hospitals
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Tuberculosis (TB) Diagnostics Market Size
2.2 Tuberculosis (TB) Diagnostics Growth Trends by Regions
2.2.1 Tuberculosis (TB) Diagnostics Market Size by Regions (2014-2025)
2.2.2 Tuberculosis (TB) Diagnostics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Tuberculosis (TB) Diagnostics Market Size by Manufacturers
3.1.1 Global Tuberculosis (TB) Diagnostics Revenue by Manufacturers (2014-2019)
3.1.2 Global Tuberculosis (TB) Diagnostics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Tuberculosis (TB) Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2 Tuberculosis (TB) Diagnostics Key Players Head office and Area Served
3.3 Key Players Tuberculosis (TB) Diagnostics Product/Solution/Service
3.4 Date of Enter into Tuberculosis (TB) Diagnostics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Tuberculosis (TB) Diagnostics Market Size by Type (2014-2019)
4.2 Global Tuberculosis (TB) Diagnostics Market Size by Application (2014-2019)

5 United States
5.1 United States Tuberculosis (TB) Diagnostics Market Size (2014-2019)
5.2 Tuberculosis (TB) Diagnostics Key Players in United States
5.3 United States Tuberculosis (TB) Diagnostics Market Size by Type
5.4 United States Tuberculosis (TB) Diagnostics Market Size by Application

6 Europe
6.1 Europe Tuberculosis (TB) Diagnostics Market Size (2014-2019)
6.2 Tuberculosis (TB) Diagnostics Key Players in Europe
6.3 Europe Tuberculosis (TB) Diagnostics Market Size by Type
6.4 Europe Tuberculosis (TB) Diagnostics Market Size by Application

7 China
7.1 China Tuberculosis (TB) Diagnostics Market Size (2014-2019)
7.2 Tuberculosis (TB) Diagnostics Key Players in China
7.3 China Tuberculosis (TB) Diagnostics Market Size by Type
7.4 China Tuberculosis (TB) Diagnostics Market Size by Application

8 Japan
8.1 Japan Tuberculosis (TB) Diagnostics Market Size (2014-2019)
8.2 Tuberculosis (TB) Diagnostics Key Players in Japan
8.3 Japan Tuberculosis (TB) Diagnostics Market Size by Type
8.4 Japan Tuberculosis (TB) Diagnostics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Tuberculosis (TB) Diagnostics Market Size (2014-2019)
9.2 Tuberculosis (TB) Diagnostics Key Players in Southeast Asia
9.3 Southeast Asia Tuberculosis (TB) Diagnostics Market Size by Type
9.4 Southeast Asia Tuberculosis (TB) Diagnostics Market Size by Application

10 India
10.1 India Tuberculosis (TB) Diagnostics Market Size (2014-2019)
10.2 Tuberculosis (TB) Diagnostics Key Players in India
10.3 India Tuberculosis (TB) Diagnostics Market Size by Type
10.4 India Tuberculosis (TB) Diagnostics Market Size by Application

11 Central & South America
11.1 Central & South America Tuberculosis (TB) Diagnostics Market Size (2014-2019)
11.2 Tuberculosis (TB) Diagnostics Key Players in Central & South America
11.3 Central & South America Tuberculosis (TB) Diagnostics Market Size by Type
11.4 Central & South America Tuberculosis (TB) Diagnostics Market Size by Application

12 International Players Profiles
12.1 Abbott
12.1.1 Abbott Company Details
12.1.2 Company Description and Business Overview
12.1.3 Tuberculosis (TB) Diagnostics Introduction
12.1.4 Abbott Revenue in Tuberculosis (TB) Diagnostics Business (2014-2019)
12.1.5 Abbott Recent Development
12.2 BD
12.2.1 BD Company Details
12.2.2 Company Description and Business Overview
12.2.3 Tuberculosis (TB) Diagnostics Introduction
12.2.4 BD Revenue in Tuberculosis (TB) Diagnostics Business (2014-2019)
12.2.5 BD Recent Development
12.3 bioMérieux
12.3.1 bioMérieux Company Details
12.3.2 Company Description and Business Overview
12.3.3 Tuberculosis (TB) Diagnostics Introduction
12.3.4 bioMérieux Revenue in Tuberculosis (TB) Diagnostics Business (2014-2019)
12.3.5 bioMérieux Recent Development
12.4 F. Hoffmann-La Roche
12.4.1 F. Hoffmann-La Roche Company Details
12.4.2 Company Description and Business Overview
12.4.3 Tuberculosis (TB) Diagnostics Introduction
12.4.4 F. Hoffmann-La Roche Revenue in Tuberculosis (TB) Diagnostics Business (2014-2019)
12.4.5 F. Hoffmann-La Roche Recent Development
12.5 Thermo Fisher Scientific
12.5.1 Thermo Fisher Scientific Company Details
12.5.2 Company Description and Business Overview
12.5.3 Tuberculosis (TB) Diagnostics Introduction
12.5.4 Thermo Fisher Scientific Revenue in Tuberculosis (TB) Diagnostics Business (2014-2019)
12.5.5 Thermo Fisher Scientific Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details